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Abstract O-linked N-acetylglucosamine transferase
(OGT) catalyzes O-GlcNAc addition to numerous cellular
proteins including transcription and nuclear pore com-
plexes and plays a key role in cellular signaling. One dif-
ferentially spliced isoform of OGT is normally targeted to
mitochondria (mOGT) but is quite cytotoxic when
expressed in cells compared with the ncOGT isoform. To
understand the basis of this selective cytotoxicity, we
constructed a fully functional ecdysone-inducible GFP–
OGT. Elevated GFP–OGT expression induced a dramatic
increase in intracellular O-GlcNAcylated proteins. Fur-
thermore, enhanced OGT expression efﬁciently triggered
programmed cell death. Apoptosis was dependent upon the
unique N-terminus of mOGT, and its catalytic activity.
Induction of mOGT expression triggered programmed cell
death in every cell type tested including INS-1, an insulin-
secreting cell line. These studies suggest that deregulated
activity of the mitochondrially targeted mOGT may play a
role in triggering the programmed cell death observed with
diseases such as diabetes mellitus and neurodegeneration.
Keywords O-GlcNAc  O-linked N-acetylglucosamine
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Introduction
O-linked N-acetylglucosamine (O-linked GlcNAc) attach-
ment to Ser/Thr residues of proteins has been termed
O-GlcNAcylation. O-linked-N-acetylglucosamine transfer-
ase (OGT) catalyzes this reversible glycan modiﬁcation of
nuclear and cytoplasmic proteins. Aneutral hexosaminidase
O-GlcNAcase removes O-GlcNAc [For reviews see
(Butkinaree et al. 2010; Hanover et al. 2010; Lazarus et al.
2009a;LoveandHanover2005;Hartetal.2007;Wellsetal.
2001)]. Despite recent advances in deﬁning the enzymes of
O-GlcNAc metabolism, the cellular function of O-GlcNA-
cylation of proteins is poorly understood. O-GlcNAcylated
proteins include oncogenes, tumor suppressors, kinases,
nuclearporeproteins,transcriptionfactors,nuclearhormone
receptors, and RNA polymerase II itself (Butkinaree et al.
2010;Hanoveretal.2010;LoveandHanover2005;Slawson
et al. 2006). Clearly OGT plays essential functions in the
regulation of transcription (Gambetta et al. 2009; Sinclair
et al. 2009; Love et al. 2010). Genetic analysis in C. elegans
alsolinksO-GlcNAcdirectlytocellsignaling(Forsytheetal.
2006; Hanover et al. 2005; Love et al. 2010). Other cellular
proteins such as the cytokeratins, tau, clathrin assembly
protein AP3, and the amyloid precursor protein (APP) are
alsoO-GlcNAcylated(Butkinareeetal.2010;Hanoveretal.
2010; Love and Hanover 2005; Slawson et al. 2006). It has
been suggested that reversible modiﬁcation by O-GlcNAc
may act in parallel with protein phosphorylation to modify
protein–protein interactions (Butkinaree et al. 2010).
O-GlcNAc may also stabilize proteins by preventing deg-
radation. Given the large number of substrates modiﬁed by
O-GlcNAc, such modiﬁcation may perform many cellular
functions (Hanover 2001; Butkinaree et al. 2010; Hanover
et al. 2010; Lazarus et al. 2009a; Love and Hanover 2005;
Hart et al. 2007; Wells et al. 2001).
D. C. Love  J. A. Hanover (&)
Laboratory of Cell Biochemistry and Biology,
NIDDK, National Institutes of Health,
Bldg 8 Rm B127, 8 Center Dr MSC 0850,
NIH, Bethesda, MD 20892-0850, USA
e-mail: jah@helix.nih.gov
URL: http://www.niddk.nih.gov/intram/people/jhanover.htm;
http://intramural.niddk.nih.gov/research/PIResearch.asp?
People_ID=1608&Title=Current%20Research:
S.-H. Shin
Gyeong-Gi Bio Center, Suwon, Korea
123
Amino Acids (2011) 40:885–893
DOI 10.1007/s00726-010-0719-8A number of ﬁndings strongly suggest that OGT may
perform a signaling function. O-linked GlcNAc transfer-
ase is well conserved across species. The higher plant
Arabidopsis has a homolog termed Spindly involved in the
gibberellin-dependent signaling pathway. Mutations in
Spindly cause constitutive activation of gibberellin sig-
naling (Banerjee et al. 2009; Chen et al. 2005; Filardo
et al. 2009; Hartweck et al. 2006; Hartweck et al. 2002;
Robertson et al. 1998; Silverstone et al. 2007). In mam-
mals, OGT is located in the X chromosome and is
essential for stem cell survival and embryonic develop-
ment in mouse (Shaﬁ et al. 2000; Hanover et al. 2003).
The OGT gene is alternatively spliced to produce a
number of differentially targeted isoforms with variable
amino termini (Hanover et al. 2003; Love et al. 2003).
The two main isoforms are targeted to the nucleus and
cytoplasm (ncOGT) and the mitochondrion (mOGT)
(Hanover et al. 2003; Love et al. 2003). After the variable
amino terminus, OGT isoforms contain 2–12 tetratrico-
peptide repeats (TPR), 34 amino acid repeat motifs
thought to mediate protein–protein interactions. The TPR
motif is found in proteins regulating cell cycle control,
transcription repression, stress response, as well as mito-
chondrial and peroxisomal protein transport (Butkinaree
et al. 2010; Hanover et al. 2010; Lazarus et al. 2009a;
Slawson et al. 2006). OGT isoforms may also contain a
nuclear localization signal and a catalytic domain with
similarities to glycogen phosphorylase and certain glyco-
syltransferases (Kreppel and Hart 1999; Lubas and
Hanover 2000; Roos and Hanover 2000). OGT transcripts
are also enriched in pancreatic beta cells (Hanover et al.
1999). These molecular features suggested that OGT iso-
forms might play a role in glucose sensing and diabetes
mellitus (Lubas et al. 1997). OGT may also play a role in
other human diseases. Streptozotocin (STZ), an analog of
GlcNAc, is a beta cell toxin and has been shown to inhibit
O-GlcNAcase (Roos et al. 1998; Hanover et al. 1999) and
the resulting elevation of O-GlcNAc levels have been
suggested to be part of the mechanism of selective beta
cell death (Liu et al. 2000). A growing body of evidence
now suggests that O-GlcNAcylation plays a key role in
the development of insulin resistance, the signature of
type 2 diabetes (McClain et al. 2002; Vosseller et al.
2002).
Insulin resistance leads to the gradual loss of Beta cell
function and overt diabetes (Liu et al. 2000; Olefsky 2001).
The hexosamine biosynthetic pathway has long been
implicated in insulin resistance (Marshall et al. 1991). A
small percentage of glucose entering cells is converted to
UDP-GlcNAc via a pathway involving the rate-limiting
enzyme glutamine fructose 6-phosphate amido transferase
(GFAT) (Brownlee 2001; Butkinaree et al. 2010; Hanover
et al. 2010; Lazarus et al. 2009b; Love and Hanover 2005;
Slawson et al. 2006). UDP-GlcNAc feedback inhibits the
activity of GFAT (Kornfeld 1967). UDP-GlcNAc then
serves as the donor for OGT (Butkinaree et al. 2010;
Hanover et al. 2010; Lazarus et al. 2009a; Love and
Hanover 2005). We demonstrated that OGT mediates the
effects of the hexosamine biosynthetic pathway in gener-
ating insulin resistance (McClain et al. 2002). Other lines
of evidence suggest that OGT may play a role in neuro-
degenerative diseases (Butkinaree et al. 2010; Hanover
2001; Hanover et al. 2010; Hart et al. 2007; Lazarus et al.
2009b; Liu et al. 2004; Love and Hanover 2005; Nakamura
et al. 2001). Human OGT is located on Xq13 where it was
previously mapped as a candidate region for Lubag syn-
drome or X-linked dystonia-parkinsonism. Hyperphos-
phorylated forms of Tau are associated with neuroﬁbrillary
tangles in Alzheimer’s disease, while it is modiﬁed by
O-GlcNAcylation in normal brain. Other neuronal proteins
such as Ankyrin, neuroﬁlaments, synapsin, and MAP1 are
also modiﬁed by O-GlcNAc (Butkinaree et al. 2010;
Hanover 2001; Hanover et al. 2010; Hart et al. 2007;
Lazarus et al. 2009b; Liu et al. 2004; Love and Hanover
2005; Nakamura et al. 2001).
O-linked GlcNAc transferase (OGT) has been sug-
gested to mediate a novel glycan-dependent signal
transduction pathway (Butkinaree et al. 2010; Hanover
et al. 2005, 2010; Love and Hanover 2005; Slawson et al.
2006; Forsythe et al. 2006). The isoforms of OGT show
interesting differences in their toxicity upon overexpres-
sion. The ncOGT isoform is largely non-toxic upon
overexpression while mOGT overexpression is cytotoxic
(Hanover et al. 2003; Lubas et al. 1997; Love et al.
2003).
In this paper, we describe an inducible expression
system for OGT where either isoform can be expressed.
Our results suggest that mOGT overexpression enhances
O-GlcNAcylation and induces apoptosis. We show that
OGT-dependent apoptosis requires OGT catalytic activity
and occurs in multiple cells including an insulinoma cell
line, INS-1. Programmed cell death is an essential mech-
anism for regulating cell number and cell fate. Our ﬁndings
suggest a role of O-GlcNAc signaling in the induction
of apoptosis. This may have important implications for
the programmed cell death associated with hexosa-
mine metabolism such as diabetes mellitus and
neurodegeneration.
Materials and methods
DNA constructions
Ecdysone-inducible, GFP-fused OGT vector, pIND/GFP–
OGT, was generated by ligating the NheI and NotI digested
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into pIND vector with the neomycin selection marker
(Invitrogen, Carlsbad, CA, USA). The orientation of this
construct is mOGT followed by GFP. C-terminal truncated
OGT, without catalytic activity, pGFP–OGT-G, was gen-
erated by ligating the XhoI digestion fragment of pGFP–
OGT into the pEGFPC2 (Invitrogen) (Lubas and Hanover
2000). pI-mOGT-G-IRES-GFP, pI-4A-mOGT-IRES-GFP,
and pI-4A-mOGT-G-IRES-GFP were derived from the
pI-mOGT-IRES-GFP construct created as described above
for pIND/GFP–OGT but using an mOGT-IRES-GFP
cassette.
Tissue culture, transfection, and isolation of a stable
cell line expressing GFP–OGT
Human embryonic kidney ﬁbroblast cell line EcR-293
(Invitrogen) (ATCC, CRL-1573) stably expresses the
functional ecdysone receptor. EcR-293 cells were grown
on six-well dishes in Dulbecco’s Modiﬁed Eagle Medium
(high glucose), 10% Fetal Bovine Serum, 2 mM L-gluta-
mine, 1% Pen/Strep, and 400 lg/ml of Zeocin. Insulin-
secreting cell line, INS-1, was maintained as described
earlier (Asfari et al. 1992). 1 lg of DNA was used for the
transfection with FuGENE 6 (Roche) according to the
manufacturer’s instructions. Stable cell lines were selected
in the presence of 800 lg/ml of G418 and positive green
ﬂuorescent cell lines were isolated using cloning cylinders
20 h after the induction with Ponasterone A. For induction,
media were changed after 23-h transfection with
FuGENE6, and ecdysone homolog Ponasterone A (Invitro-
gen) was added into fresh media and incubated for another
20 h before the observation of induced expression of GFP
fused proteins.
Immunoblot analysis
After induction with the ecdysone homolog Ponasterone A,
cells were lysed in the presence of 10 mM leupeptin,
10 mg/ml aprotinin, and 17.4 mg/ml PMSF and boiled for
1 min at 98C before loading. The proteins were resolved
using 4–12% Tris–Glycine buffered SDS/PAGE analysis.
Separated proteins were transferred onto nitrocellulose and
induced GFP–OGT was detected by using 1:200 diluted
GFP peptide antibody (CLONTECH), followed by 1:4,000
diluted horseradish peroxidase (HRP)-conjugated goat anti-
rabbit antibody (Jackson ImmunoResearch). O-linked
N-acetylglucosaminylated proteins were detected by using
the diluted RL2 mouse monoclonal IgG1 (1:5,000) anti-
body (Afﬁnity BioReagents), followed by 1:1,000 diluted
HRP-conjugated anti-mouse antibody. Enhanced chemilu-
minescence (ECL) detection method (Amersham) was used
to develop images.
Immunocytochemistry
Cells were grown on the coverslips for 24 h. After washing
with phosphate-buffered saline (PBS), cells were incubated
with 4% formaldehyde for 30 min. Formaldehyde-ﬁxed
cells were washed twice with PBS and then permeabilized
with 0.2% Triton X-100 for 2 min. Cells were rinsed with
PBS four times over 5 min. In a humidiﬁed chamber, cells
were incubated with 1:100 diluted RL2 in 3% bovine
serum albumin (BSA) for 45 min. After washing with PBS,
cells were incubated with 1:100 diluted FITC-conjugated
anti-mouse antibody for 20 min.
Fluorescence and light microscopy
Fluorescence images were taken using an Axiovert 100 TV
(Zeiss) with IPLab scientiﬁc imaging software (Scanalyt-
ics) or LSM410 confocal microscope (Zeiss) with its Zeiss
LSM 410 software. Optical images from TUNEL assays
were obtained with Hamamatsu C5810 color chilled 3CCD
camera (Hamamatsu).
TUNEL (terminal deoxynucleotidyl
transferase-mediated dUTP nick translation) assay
Programmed cell death (apoptosis) was detected immuno-
histochemically using horseradish peroxidase (HRP)
according to the manufacturer’s instructions as described
below (Roche). Cells were ﬁxed with freshly made 4%
paraformaldehyde for 1 h. Cells were rinsed with PBS
between each step. To block endogenous peroxidase, cells
were incubated with 3% hydrogen peroxide in methanol for
10 min. Cells were permeabilized with 0.1% Triton X-100
in 0.1% sodium citrate for 2 min at 4C. Bovine pancreatic
deoxyribonuclease I (Boeringer Mannheim) was used to
cleave DNA for the positive control of the assay. Terminal
deoxynucleotidyl transferase (TdT) from calf thymus was
added to the cells in a ﬂuorescein-labeled nucleotide
mixture reaction buffer for 1 h at 37C. HRP-conjugated
anti-ﬂuorescein antibody was added to incubate cells for
30 min at 37C. Cells were incubated with DAB substrate
for 10 min followed by light microscopy.
Annexin V apoptosis assay
Annexin V-Biotin Apoptosis detection kit (ALEXIS Bio-
chemicals) was used according to the manufacturer’s
instructions as described below. Cells on the coverslips
were rinsed with PBS twice. Cells were incubated with 5 ll
of Annexin V-Biotin and 200 llo f1 9 binding buffer for
5 min in the dark. Cells were washed once in 200 llo f1 9
binding buffer. Cells were ﬁxed with 2% formaldehyde for
15 min and resuspended with 100 ll of 0.1% BSA in PBS.
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1235 lg/ml of streptavidin–rhodamine was added and incu-
bated for 15 min followed by ﬂuorescence microscopy.
Camptothecin (3 lg/ml) was used to induce apoptosis for
the positive control of apoptosis.
DNA ladder apoptosis assay
ApoAlert LM-PCR ladder assay kit (CLONTECH) was
used following the manufacturer’s instructions as summa-
rized below. Genomic DNA was mixed with adapter DNA
in ligation mix and heated to 55C for 10 min and allowed
to cool to 10C over 1 h. T4 ligase was added to the tube
and incubated at 16C overnight. PCR reaction of adaptor-
ligated DNA was incubated for 3 min at 72C and then
added to Advantage cDNA Polymerase mix and ampliﬁed
according to manufactures instructions (CLONTECH).
Calf thymus DNA was used for the positive control.
Nucleosomal ladder appears as multiples of approximate
200 bp.
Results
Previously, we showed that transient overexpression of the
mitochondrial form of OGT (mOGT) increased cellular
OGT activity, but was cytotoxic (Hanover et al. 2003;
Lubas et al. 1997). Overexpression of the ncOGT isoform
did not show obvious cytotoxicity. To understand the basis
for the selective cytotoxicity, we have developed a condi-
tional expression system of OGT in mammalian cell lines.
We used an ecdysone-inducible gene expression system
(outlined in Fig. 1). To identify the subtle difference
of OGT expression in the cells, we ﬁrst added the green
ﬂuorescence protein (GFP) as a second marker and an
internal ribosomal entry site (IRES). When this construct
was transfected into cells, in the presence of the ecdysone
analog ponasterone A, the ecdysone-dependent inducible
promoter directed the production of a bicistronic transcript
encoding two proteins: mOGT and GFP, which is translated
independently using the IRES. We observed colonies from
stably transfected cells under selective pressure of G418 in
the absence of ponasterone A. We could not generate a
stable cell line from the dishes transfected with pI-mOGT-
IRES-GFP. However, we got stable cell lines stably
expressing the inactive pI-mOGT-G-IRES-GFP, containing
C-terminal deletion. Interestingly, we observed an order of
magnitude higher number of colonies derived from either
pI-4A-mOGT-IRES-GFP (containing a N-terminal dele-
tion) or pI-4A-mOGT-G-IRES-GFP (containing both N-and
C-terminal deletions) (Fig. 1) in comparison with the dishes
Fig. 1 Inducible expression of mOGT in IRES bicistronic vectors
leads to toxicity requiring proper targeting and catalytic activity.
1. pI-mOGT-IRES-GFP has the full length OGT gene placed after an
ecdysone-inducible promoter and an internal ribosomal entry site is
located between OGT and GFP. This vector is used as a backbone for
the derivatives described below. 2. pI-mOGT-G-IRES-GFP contains a
C-terminal deletion represented by dotted lines (DC-term-del). This
catalytically defective mOGT replaces the full length wild-type
mOGT. 3. pI-mOGT-4A-IRES-GFP contains a deletion (dotted lines)
of the 15 N-terminal amino acids thought to be involved in
mitochondrial targeting (MLQGHFWLREGIMIS) and has an added
histidine tag (solid red stripe) at the N-terminus (DN-term-del ? His
tag). 4. pI-mOGT-4A-G-IRES-GFP is catalytically defective and
contains both C-terminal and N-terminal deletions plus the histidine
tag described for vectors 2 and 3, respectively. These plasmids were
transfected into EcR-293 cells and the surviving colonies were
selected with G418 as described. Colonies were counted to quantify
the degree of toxicity for each construct. The minus sign means no
colonies were observed. There is roughly an order of magnitude
difference between one plus and two plus signs. Approximate colony
numbers are shown. The colony count was carried out in triplicate and
a summary of the three experiments is presented
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123transfected with pI-mOGT-G-IRES-GFP. With bicistronic
constructs, we saw a minimal level of transient or stable
expression of either mOGT or GFP in the absence of
ponasterone A. These experiments suggested that upon
removal of the 15 amino acid N-terminus of mOGT (pI-4A-
mOGT-IRES-GFP), or by inactivating the catalytic domain
of mOGT by truncation (pI-mOGT-G-IRES-GFP), much of
the toxicity of mOGT was eliminated.
In another series of experiments, GFP was directly
appended to the amino terminus of the 103-kDa isoform of
mOGT and placed under the control of the ecdysone pro-
moter, pIND/GFP–OGT (Fig. 2a). This allowed direct
visualization and detection of the mOGT transgene.
Expression of this fusion protein was monitored by
immunoblotting (Fig. 2b–d). Increasing concentrations of
Ponasterone A induced expression of the fusion protein.
This expression was detected by an anti-OGT antibody
(Fig. 2b) or an anti-GFP antibody (Fig. 2c, d). The level of
expression observed when fully induced compared favor-
ably with that seen using a CMV promoter, pGFP–OGT
(Fig. 2b, c; compare lanes 5 and 6). Longer exposures of
the immunoblots revealed that even at low levels of
Ponasterone A, induction of OGT occurred (Fig. 2d).
These data suggest that the ecdysone system allowed
exquisite control over the levels of OGT expression.
To conﬁrm that the GFP–OGT fusion protein was cat-
alytically active, the levels of O-GlcNAc were examined
using anti-O-GlcNAc antibodies and immunoblotting and
immunoﬂuorescence microscopy (Fig. 3). Increasing con-
centrations of Ponasterone A lead to increased O-GlcNAc
levels on several cellular proteins (Fig. 3a). By immuno-
ﬂuorescence, we observed a substantial increase in
O-GlcNAc in those cells induced to express the GFP–OGT
fusion protein; no elevation was observed in those cells not
expressing the fusion protein (Fig. 3b, pIND/GFP–OGT).
Similar results were observed when a constitutive CMV
promoter (pGFP–OGT) was used (Fig. 3b, pGFP–OGT).
When we expressed a GFP–OGT fusion with a truncation
in the catalytic domain, which renders it inactive (Lubas
and Hanover 2000), O-GlcNAc levels were not elevated
(Fig. 3b, pGFP–OGT-G). These data suggest that GFP–
OGT is catalytically active when expressed in cells; this
activity requires an intact OGT catalytic domain.
We then examined the effects of elevated O-GlcNAc
levels on cell viability. The cellline EcR-293 (a kidney line)
was chosen because it contains low levels of OGT (Lubas
et al. 1997; Kreppel et al. 1997) and stably expresses ecdy-
sone receptor which facilitates the ecdysone induction.
Transient overexpression of catalytically active OGT was
found to induce apoptosis as measured by the TUNEL assay
(Fig. 4a, pGFP–OGT). The apoptosis was dependent upon
catalytic activity since the transfection with the C-terminus
deleted, catalytically defective, mutation of OGT did not
result in TUNEL-positive cells (Fig. 4b, pGFP–OGT-G).
We generated an EcR-293 cell line expressing ecdy-
sone-inducible GFP–OGT (pIND/GFP–OGT) and exam-
ined the response of these cells to increasing concentrations
of Ponasterone A (Fig. 4e–g). The TUNEL-positive cells
increased in number and intensity in response to hormone
treatment. Treatment of 293 cells that did not express
GFP–OGT with high levels of Ponasterone A (Fig. 4h, no
plasmid) did not induce apoptosis. We have also conﬁrmed
these ﬁndings using an Annexin V assay (Fig. 4i–l). Cells
expressing GFP–OGT (Fig. 4i) were positive (Fig. 4j) for
Annexin V. Cells not expressing GFP–OGT were Annexin
V negative (Fig. 4k). The apoptosis inducing drug, cam-
pothecin, rendered all cells Annexin V-positive (Fig. 4l).
Fig. 2 Inducible expression of mOGT in EcR293 cells. a Diagram of
the GFP–mOGT construct under the control of an inducible promoter
(pIND/GFP–OGT). b Western blot analysis using an anti-OGT
antibody to compare expression levels of pIND/GFP–OGT with
increasing amounts of Ponasterone A (PoA) to a CMV-driven GFP–
OGT fusion (pGFP–OGT). c Western blot analysis of same samples
using an anti-GFP antibody. For b and c EcR-293 cells were
transfected with pIND/GFP–OGT and incubated without Ponasterone
A(PoA) (lane 1), or with the following concentration of PoA: 0.1 lM
(lane 2), 0.5 lM( lane 3), 3.0 lM( lane 4), 15.0 lM( lane 5). Cells
were also transfected with the CMV-driven plasmid pGFP–OGT
(lane 6). On the right side are molecular weight markers. d Longer
exposure of the Western blot shown in c between lanes 2 and 4 at
140 kDa range
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123Fig. 3 O-GlcNAcylation is consistent with GFP-fused OGT expres-
sion, but not with mutant, catalytically defective, OGT. a Western
blot analysis reveals that induction of GFP-fused OGT expression
with increasing concentrations of Ponasterone A (PoA) (0.5, 3,
15 lM, respectively) causes an increase in the levels of total
O-GlcNAc modiﬁcation. The level of O-GlcNAc modiﬁed proteins
prior to induction is shown in the last lane (-). The anti-O-GlcNAc
antibody, RL2, was used in the Western Blot analysis. b Immunoﬂu-
orescent detection of GFP-fused OGT expression and its catalytic
activity using RL2 staining. RL2 speciﬁcally recognizes O-GlcNA-
cylated proteins. pGFP–OGT-G is the c-terminal deleted, catalytically
defective OGT under CMV-driven promoter
Fig. 4 Overexpression of catalytically active GFP–OGT induces
apoptosis. a CMV-driven expression of the mitochondrial form of
OGT (pGFP–OGT) induces apoptosis as shown by the TUNEL assay.
b A catalytically inactive form of OGT (pGFP–OGT-G) does not
induce apoptosis. EcR-293 cells were used for transfections in a and
b. c and d An insulinoma cell line, INS-1, was transfected with active
OGT (pGFP–OGT). The TUNEL assay was used to reveal apoptotic
cells. Representative focal planes near the bottom (c) and top (d)o f
INS-1 cell clusters are shown. Note the apoptotic cells on the outer
layer of cells in the clusters. Black and red arrows denote cells scored
as positive by the TUNEL assay. e–g EcR-293 cells were transfected
with GFP–OGT (pIND/GFP–OGT) and induced with Ponasterone A
(PoA) at indicated concentrations. Note the increasing amount of
TUNEL-positive cells (black arrows)i ng and h compared with the
two negative controls e and h pIND/GFP–OGT, no PoA and no
plasmid, 15 lM PoA, respectively. i–l Annexin V staining was used
to identify apoptotic cells. i EcR-293 cells were treated with 3.0 lM
of Ponasterone A to induce expression of pIND/GFP–OGT (green).
j Same ﬁeld stained with an anti-annexin V antibody to reveal
apoptotic cells (red). Note near-complete colocalization of GFP–OGT
expression and Annexin V staining (compare i and j). k Untreated
cells did not stain positive for Annexin V. l As a positive control for
apoptosis, 4 l/ml camptothecin was added to uninduced cells.
m DNA ladder assay. Genomic DNA from pIND/GFP–OGT trans-
fected cells (lanes 1–5) was separated on an agarose gel to reveal
DNA laddering. Uninduced cells are shown in lane 1. Increasing
amounts of Ponasterone A were added at the following concentra-
tions: 0.1 lM( lane 2), 0.5 lM (lane 3), 3.0 lM( lane 4), 15.0 (lane
5). The DNA laddering from CMV-driven expression of pGFP–OGT
(lane 6) is comparable to the commercially available positive control
from Calf thymus (lane 7). DNA size markers of 100 bp (lane 8) and
1 kb DNA (lane 9) are shown
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was obtained by a DNA ladder assay (Fig. 4m). Increasing
concentrations of ecdysone (Lanes 2–5) caused DNA lad-
dering, identical to that seen in a positive control (Lane 7).
Similar results were obtained using unmodiﬁed mOGT
under the control of the CMV promoter (Lane 6). Taken
together, these ﬁndings strongly suggest that elevation in
the levels of cellular mOGT induces apoptosis in EcR-293
cells. We were interested in seeing whether the apoptotic
effect observed with elevated OGT expression was
restricted to kidney ﬁbroblast-derived EcR-293 cells. We
chose to examine the effects of elevated OGT expression in
the insulinoma-derived INS-1 cell line since this cell line
has many similarities to pancreatic beta cells. Many
TUNEL-positive apoptotic cells were found in INS-1 cells
following transfection with the mOGT (Fig. 4c, d). OGT-
induced apoptosis was also observed in HeLa cells and
CHO cells (data not shown). Thus, triggering of apoptosis
appears to be a general cellular response to elevated mOGT
expression.
Discussion
Our ﬁndings regarding elevated mOGT expression and the
triggering of apoptosis are intriguing in light of more recent
ﬁndings linking the hexosamine biosynthetic pathway with
other signaling pathways including those involved in pro-
grammed cell death and mitochondrial function. The role
of the hexosamine biosynthetic pathway in insulin signal-
ing is well documented. First, we have shown that over-
expression of OGT in muscle and fat of transgenic mice
induces insulin resistance (McClain et al. 2002). Similar
conclusions were reached in L1-3T3 cells using an inhib-
itor of O-GlcNAc removal to elevate O-GlcNAc levels
(Vosseller et al. 2002). These effects appear to be linked to
alteration of the AKT-signaling pathway. This kinase is
associated with numerous signaling pathways including the
insulin-signaling pathway and the pathways controlling
apoptosis (Butkinaree et al. 2010; Hanover et al. 2010;
Lazarus et al. 2009a; Slawson et al. 2006). We have shown
that several kinases associated with this cascade, including
casein kinase II and GSK3b are substrates for OGT (Lubas
and Hanover 2000; Lazarus et al. 2006). In addition,
O-GlcNAc is associated with beta cell destruction in a
process involving apoptosis (Liu et al. 2000). Glucosamine
administration has been shown to induce programmed cell
death in tissue culture (Liu et al. 2000; Tang et al. 2000).
Glucosamine also blocks the neuroprotective effect of
insulin and induces apoptosis in retinal neurons (Nakamura
et al. 2001). O-GlcNAc levels must be tightly controlled in
cardiac tissue (Champattanachai et al. 2007; Champatta-
nachai et al. 2008; Fulop et al. 2007; Laczy et al. 2009;W u
et al. 2009). Increased O-GlcNAcylation of mitochondrial
proteins impairs mitochondrial function in cardiac myo-
cytes exposed to high glucose (Hu et al. 2009). On the
other hand, glucosamine protects neonatal cardiomyocytes
from injury via increased Bcl-2 and O-GlcNAc (Champ-
attanachai et al. 2008).
More direct evidence that hexosamine synthesis is
involved in apoptotic signaling derives from studies of
MEFs deﬁcient in glucosamine-6-phosphate (GlcN6P)
acetyltransferase (EMeg32). These ﬁbroblasts produce very
low levels of UDP-GlcNAc (Boehmelt et al. 2000) and
lower levels of O-GlcNAc modiﬁed cytosolic and nuclear
proteins while other pathways are unaffected. Interestingly,
growth-impaired EMeg32 (-/-) MEFs withstand a num-
ber of apoptotic stimuli and express activated PKB/AKT.
These ﬁndings strongly suggest that UDP-GlcNAc levels
inﬂuence cell cycle progression and susceptibility to
apoptotic stimuli. By utilizing UDP-GlcNAc to modify
cellular proteins, OGT may induce apoptosis in response to
elevated ﬂux through the hexosamine signaling pathway. In
addition to our current ﬁndings, the most direct evidence
for a role of OGT in apoptotic signaling derives from a
screen of anti-apoptotic genes in leukemia cells (Fletcher
et al. 2002). In parallel with our studies on OGT isoforms, a
functional retroviral cDNA library-based screen was
employed to identify genes that prevent growth factor
withdrawal-mediated apoptosis in a myeloid progenitor
cell. This approach identiﬁed a truncated form of OGT as
an anti-apoptotic factor (Fletcher et al. 2002). Based on the
properties of the protein, these authors argued that the
truncated form of OGT identiﬁed was functioning as a
dominant negative inhibitor of OGT. The coding sequence
of OGT identiﬁed by Fletcher et al. (2002), corresponds to
a form of OGT we have referred to as sOGT (Hanover
et al. 2003; Love et al. 2003), a short splice variant of
approximately 78 kDa derived from the OGT gene. This
OGT isoform has nearly two complete and one partial TPR
motifs. It is substantially shorter than the 103-kDa mOGT
isoform used in this study, but contains the intact catalytic
domain of OGT. Many apoptotic-signaling molecules such
as bax have a corresponding family member that is anti-
apoptotic (such as bcl-2, bcl-x or mcl-1). These observa-
tions raise the possibility that mOGT and sOGT represent
pro- and anti-apoptotic partners involved in regulating
apoptosis. Their balance may be essential for regulating
programmed cell death. These studies also suggest a
mechanism by which elevated ﬂux through the hexosa-
mine-signaling pathway may be linked to apoptosis. The
programmed cell death may have relevance for Beta cell
loss in diabetes mellitus, and numerous other human dis-
eases undergoing apoptosis.
We note, with great interest, that the ncOGT interacts
with Ataxin-10 in the brain and pancreas and that the sOGT
Elevated O-GlcNAc-dependent signaling through inducible mOGT 891
123variant interferes with this interaction (Andrali et al. 2005;
Marz et al. 2006). These ﬁndings and the ﬁndings outlined
above suggest that each of the isoforms of OGT may be
key regulators of pro-survival mechanisms in the nucleus,
cytoplasm and mitochondrion. Further work will be
required to thoroughly understand the signiﬁcance of these
many interactions.
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